¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Drug Resistance, Viral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • drug-induced hepatitis
    ¾à¹°À¯¹ß°£¿°
  • drug-induced immune complex
    ¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
  • drug-induced jaundice
    ¾à¹°À¯¹ßȲ´Þ
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • drug-induced retinopathy
    ¾à¹°À¯¹ß¸Á¸·º´(Áõ)
  • drug-induced rhinitis
    ¾à¹°À¯¹ßÄÚ¿°, ¾à¹°À¯¹ßºñ¿°
  • drug-resistant
    ¾à¹°ÀúÇ×-
  • designer drug
    º¯Á¶¾à¹°
  • fixed drug eruption
    °íÁ¤¾à¹°¹ßÁø, °íÁ¤¾àÁø
  • gateway drug
    Åë·Î¼ö´Ü¾à¹°, ½À°üÇü¼º¾à¹°
  • generic drug name
    ÀϹݾà¸í
  • hallucinogenic drug
    ȯ°¢Á¦
  • idiosyncratic drug response
    ƯÀ̾๰¹ÝÀÀ
  • inotropic drug
    ¼öÃàÃËÁø¾à
  • mucosal protective drug
    Á¡¸·º¸È£Á¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • drug potentiation
    ¾à¹°°­È­ÀÛ¿ë, ¾à¹°»ó½ÂÀÛ¿ë
  • drug psychosis
    ¾à¹°Á¤½Åº´
  • drug rash
    ¾à¹°¹ßÁø, ¾àÁø
  • drug therapy
    ¾à¹°¿ä¹ý
  • drug tolerance
    ¾à¹°³»¼º, ¾à¹°ÀúÇ×¼º
  • drug treatment
    ¾à¹°Ä¡·á
  • drug withdrawal
    ¾à¹°±Ý´Ü
  • drug delivery system
    ¾à¹°Àü´Þü°è
  • drug level monitoring
    ¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
  • drug utilization review
    ¾à¹°»ç¿ë°ËÅä
  • drug-induced hemolysis
    ¾àÁ¦À¯¹ß¿ëÇ÷
  • drug-induced hepatitis
    ¾à¹°°£¿°
  • drug-induced jaundice
    ¾à¹°À¯¹ßȲ´Þ
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • drug-induced retinopathy
    ¾àÀ¯¹ß¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • residual resistance
    ÀÜ·ùÀúÇ×(¡­î½ù÷).
  • resistance
    ÀúÇ×(î½ù÷)
  • resistance
    ³»¼º.
  • resistance amplification
    ÀúÇ×ÁõÆø(î½ù÷ ñòøë).
  • resistance coil
    ÀúÇ×ÄÚÀÏ.
  • resistance conveyance
    ³»¼ºÀü´Þ(Ò±àõ îîÓ¹).
  • resistance donor
    ³»¼º°ø¿©±Õ
  • resistance factor
    ³»¼ºÀÎÀÚ(¡­ì×í­).
  • resistance furnace
    ÀúÇ×·Î(î½ù÷ÖÓ).
  • resistance limit of gold alloy
    ±ÝÇձݳ»»êÇѵµ(ÐÝùêÐÝұ߫ùÚöô).
  • resistance reflex
    ÀúÇ׹ݻç(î½ù÷ÚãÞÒ).
  • resistance to antibiotic
    Ç×»ýÁ¦ÀúÇ×¼º(ù÷ßæð¥î½ù÷àõ), Ç×»ýÁ¦³»¼º(ù÷ßæð¥ Ò±àõ).
  • resistance to antibiotics
    Ç×»ýÁ¦ÀúÇ×¼º(ù÷ßæð¥î½ù÷àõ), Ç×»ýÁ¦³»¼º(ù÷ßæð¥ Ò±àõ).
  • resistance to corrosion
    ³»½Ä¼º(Ò±ãÚàõ).
  • resistance to infection
    °¨¿°ÀúÇ×¼º(Êïæøî½ù÷àõ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
VGP viral glycoprotein
VH vaginal hysterectomy; venous hematocrit; ventricular hypertrophy; veterans hospital; viral hepatitis...
VHD valvular heart disease; viral hematodepressive disease
VHF very high frequency; viral hemorrhagic fever; visual half-field
Vir virus, viral
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
APD antipsychotic drug
CAD cationic amphiphilic drug
CDER Center for Drug Evaluation and Research
CIDR Controlled Internal Drug Release
DARP Drug Abuse Reporting Program
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fixed drug enanthema
    °íÁ¤ ¾à¹°¼º Á¡¸·Áø
  • Food and Drug Administration
    ½ÄǰÀǾà±â±¸
  • habit forming drug
    ½À°ü¼º ¾àǰ
    À°Ã¼Àû ¶Ç´Â Á¤½ÅÀûÀ¸·Î ÀÇÁ¸¼ºÀ» °®°Ô ÇÏ´Â ¾à¹°.
  • hydantoinlike drug
    È÷´ÜÅäÀÎ¾ç ¾àÁ¦
  • hydrophilic drug
    Ä£¼ö¼º ¾àÁ¦
  • immunosuppressive drug
    ¸é¿ª ¾ïÁ¦Á¦
    »ýüÀÇ ¸é¿ª ¹ÝÀÀÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦. »ýü ³»¿¡¼­ ¸é¿ª ¹ÝÀÀÀ¸·Î Á¶Á÷ÀÌ Àå¾Ö¸¦ ¹Þ¾Æ º´ÀÌ ÀϾ´Â °æ¿ì°¡ ÀÖ´Ù. ƯÈ÷, Ç׿ø ¹°ÁúÀÌ ÀÚ±âÀÇ Ã¼¼ººÐÀÏ °æ¿ì¿¡´Â ÀÚ°¡ ¸é¿ª ÁúȯÀ̶ó°í ÇÑ´Ù. ÀÚ°¡ ¸é¿ª Áúȯ¿¡¼­´Â ´ë°³ÀÇ °æ¿ì, Á¦ 1¼±ÅÃÁ¦·Î¼­ ºÎ½Å ÇÇÁú È£¸£¸óÀÌ ¾²À̸ç, À̰Ϳ¡ ÀúÇ×À» ³ªÅ¸³»´Â µî ÇѰ谡 ÀÖÀ» °æ¿ì°¡ ÀÖ´Ù. ÀÌ·¯ÇÑ ¶§ ¸é¿ª ¹ÝÀÀÀ¸·Î ÀÎÇÑ º´Å¿¡ ´ëÇÏ¿©, À̸¦ ¾ïÁ¦Çϰí Ä¡·áÇϱâ À§ÇÏ¿© ¸é¿ª ¾ïÁ¦Á¦°¡ »ç¿ëµÈ´Ù. ¶Ç Àå±â ÀÌ½Ä ¶§ °ÅºÎ ¹ÝÀÀÀ» ¾ïÁ¦Çϱâ À§Çؼ­µµ »ç¿ëµÈ´Ù. ¸é¿ª¾ïÁ¦¿¡´Â ±× ¹ÝÀÀ¸¸À» ¾ïÁ¦Çϴ ƯÀÌÇÑ °Í°ú ±×·¸Áö ¾ÊÀº °ÍÀÌ ÀÖÀ¸¸ç, ÀÌ·ÐÀûÀ¸·Î´Â ƯÀÌÇÑ ÂÊÀÇ ÀÛ¿ëÀÌ ¶Ù¾î³ª¾ß ÇϰÚÁö¸¸, ÀÓ»óÀûÀ¸·Î ¾²ÀÌ´Â °ÍÀº °ÅÀÇ ºñƯÀÌÀû ¸é¿ª ¾ïÁ¦Á¦ÀÌ´Ù. ºñƯÀÌÀû ¸é¿ª ¾ïÁ¦Á¦¿¡´Â »çÀÌŬ·ÎÆ÷½ºÆÄ¹Ìµå, ´ÏÆ®·Î°Õ¸¶½ºÅ¸µå µîÀÇ ¾ËųȭÁ¦, 6-¸Þ¸£Ä°ÅäǪ¸°, ¾ÆÀÚÆ¼¿ÀǪ¸°, ½ÃÅä½Å¾Æ¶óºñ³ë½Ãµå µî°ú °°Àº ´ë»ç ±æÇ×Á¦, ¹ÌÅ丶À̽ŠC, ¾ÇƼ³ë¸¶À̽ŠD µîÀÇ Ç×»ý ¹°Áú, ºÎ½Å ÇÇÁú ½ºÅ×·ÎÀ̵åÁ¦, ºó¾ËÄ®·ÎÀ̵åÁ¦, Ç׸²ÇÁ±¸ Ç÷û µîÀÇ Ç×ü µî ¿©·¯ Á¾·ùÀÇ ¾àÁ¦°¡ ÀÖ´Ù. ÀÌµé ¸é¿ª ¾ïÁ¦Á¦´Â Ç׿ø Àڱؿ¡¼­ Ç×ü »ý¼º±îÁö À̸£´Â µ¿¾È¿¡, ¸ÅÅ©·ÎÆÄÁö¿¡ ÀÇÇÑ Ç׿øÀÇ Å½½Ä, ¸²ÇÁ±¸¿¡ ÀÇÇÑ Ç׿ø ÀνÄ, ¼¼Æ÷ ºÐ¿­, T ¼¼Æ÷¿Í B ¼¼Æ÷ÀÇ ºÐ¿­, Ç×ü »ý¼º µî ¸î °¡Áö °úÁ¤À» ÀúÇØ½ÃÅ´À¸·Î½á ¸é¿ª¾ïÁ¦¸¦ ¾ß±â½ÃŲ´Ù. ´ëºÎºÐÀÌ Ç×Á¾¾ç Ȱ¼ºÀ» °¡Áö°í À־, DNA
  • individual drug
    °³°³ÀÎ ¾à¹°
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£ Ç¥Çö
  • lichenoid drug reaction
    ż±¾ç ¾à¹° ¹ÝÀÀ
  • like drug
    ¸ð¸£ÇÉ À¯»ç ¾à¹°
  • long acting drug
    Áö¼Ó¼º ¾à
  • metabolic drug
    ´ë»ç ¾à¹°
  • misbranded drug
    ºÎÁ¤ Ç¥½Ã ¾àǰ
  • morphine like drug
    ¸ð¸£ÇÉ À¯»ç ¾à¹°
  • multiple drug misuse
    ¿©·¯ ¾à¹°ÀÇ ¿À¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
DNA, viral Deoxyribonucleic acid that makes up the genetic material of viruses.
(12 Dec 1998)
duck viral enteritis A viral enteritis of ducks and other waterfowl in Europe, Asia, and the U.S. Caused by an anatid herpes virus 1; manifested by weakness, lethargy, and diarrhoea accompanied by catarrhal haemorrhagic enteritis and echymotic haemorrhages in organs and muscles.
Synonym: duck viral enteritis.
(05 Mar 2000)
duck viral hepatitis An acute, highly contagious disease of young ducklings caused by an enterovirus and characterised by lethargy, spasmodic paddling and rapid death.
(05 Mar 2000)
inclusion bodies, viral An area showing altered staining behaviour in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent "virus factories" in which viral nucleic acid or protein is being synthesised; others are merely artifacts of fixation and staining. One example, negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies.
(12 Dec 1998)
oncogene proteins, viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities.
(12 Dec 1998)
encephalitis, viral Inflammation of the brain caused by viruses. When this is caused by encephalitis viruses, a group of arboviruses, it is referred to as epidemic encephalitis (encephalitis, epidemic). Other viruses, including some herpes viruses, also cause viral encephalitis.
(12 Dec 1998)
equine viral arteritis A highly contagious viral disease caused by equine arteritis virus, member of the family Togaviridae, and characterised by a high fever and respiratory and digestive tract signs; the essential lesions involve smaller arteries, with necrosis which may be followed by thrombosis, infarction, haemorrhages, and oedema; abortion is a common result.
Synonym: epizootic cellulitis, equine typhoid.
(05 Mar 2000)
eye infections, viral Infections of the eye caused by minute intracellular agents. These infections may lead to severe inflammation in various parts of the eye - conjunctiva, iris, eyelids, etc. Several viruses have been identified as the causative agents. Among these are herpes virus, adenovirus, poxvirus, and myxovirus.
(12 Dec 1998)
feline viral rhinotracheitis An acute upper respiratory tract infection of cats caused by the feline rhinotracheitis virus; it is frequently fatal in kittens but mild in adults, who sometimes become convalescent carriers of the virus.
(05 Mar 2000)
abnormalities, drug-induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
(12 Dec 1998)
activity, drug A measure of the physiological response a drug produces in the body. A less active drug produces less response (and visa versa).
(12 Dec 1998)
addictive drug Any drug that creates a certain degree of euphoria and has a strong potential for addiction.
(05 Mar 2000)
adverse drug reaction reporting systems Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.
(12 Dec 1998)
akathisia, drug-induced Motor restlessness with sensations of quivering and an urge to move about constantly resulting from the use of certain drugs, such as neuroleptic drugs, which affect the extrapyramidal region of the brain. This differs from dyskinesia, drug-induced in that long-term antipsychotic drug exposure is significantly correlated with the increased prevalence of akathisia while there is no such correlation with dyskinesia. The primary observable distinction between tardive akathisia and dyskinesia appears to be in the repetitive, stereotypy of the dyskinesic movements (lip smacking, for example), while akathisia is associated with anxiety, restlessness, and agitation (psychomotor agitation).
(12 Dec 1998)
antineoplastic drug A drug that stops or slows the maturation and spread of tumour cells (benign or malignant).
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á